Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.59 |
| ▸ | MAOA | P21397 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 2/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248078 | 0.91 | NPC1 (0.56) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL28446692 | 0.90 | LMNA (0.55) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL2145960 | 0.88 | LMNA (0.53) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL28659060 | 0.88 | LMNA (0.53) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL28446693 | 0.88 | LMNA (0.53) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL30790800 | 0.86 | LMNA (0.52) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL5781148 | 0.85 | LOXL2 (0.61) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL10475419 | 0.84 | LMNA (0.50) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL6228872 | 0.84 | LMNA (0.59) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL1417358 | 0.84 | PBRM1 (0.52) | LMNACYP1A2CYP3A4MAOATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115724815-A | Dianhydride monomer containing amide structure and trifluoromethyl, polyimide film and preparation method thereof | 安徽国风新材料股份有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-112521603-A | Polyamide acid block copolymer and preparation method thereof, polyimide copper-clad plate and circuit board | 臻鼎科技股份有限公司 | 2021-03-19 | — | — | CN | claimed |
| CN-112239539-A | Polyamide acid composition, polyimide copper-clad plate and circuit board | 臻鼎科技股份有限公司 | 2021-01-19 | — | — | CN | claimed |
| US-20180273819-A1 | THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS COMPRISING TRIAMINES AND METHODS FOR MAKING AND USING THEM | ENTROPY SOLUTIONS LLC (US) | 2018-09-27 | — | — | US | claimed |
| WO-2016179028-A1 | THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS AND METHODS FOR MAKING AND USING THEM | ENTROPY SOLUTIONS, LLC. (US) | 2016-11-10 | — | — | WO | claimed |
| WO-2025015175-A2 | HEATING, VENTILATION, AND AIR CONDITIONING (HVAC) SYSTEMS AND METHODS FOR USING SAME | STASIS ENERGY GROUP, LLC (US) | 2025-01-16 | — | — | WO | disclosed |
| US-20240254082-A1 | Substituted Isoindoline-1, 3-diketone PDE4 Inhibitor and Pharmaceutical Application Thereof | SUZHOU INTRAGRAND PHARMA CO., LTD (CN) | 2024-08-01 | — | — | US | disclosed |
| CN-118236408-A | Novel method for antagonizing toxicity of metalloid As based on magnetotactic bacteria AMB-1 | 中国科学院合肥物质科学研究院 | 2024-06-25 | — | — | CN | disclosed |
| EP-4385976-A1 | SUBSTITUTED ISOINDOLIN-1,3-DIONE PDE4 INHIBITOR AND PHARMACEUTICAL USE THEREOF | Suzhou Intragrand Pharma Co., Ltd (CN) | 2024-06-19 | — | — | EP | disclosed |
| EP-3431547-B1 | AQUEOUS DISPERSION, COMPRISING A CURABLE POLYESTER, RESOLE PHENOLIC RESINS AND WATER | EASTMAN CHEM CO (US) | 2023-10-25 | — | — | EP | disclosed |
| CN-115873417-B | Disazo benzimidazolone pigment containing isosorbide structure and preparation method thereof | 江苏丽王科技股份有限公司 | 2023-10-17 | — | — | CN | disclosed |
| EP-3428231-B1 | CURABLE POLYESTERS AND THERMOSETTING COMPOSITIONS CONTAINING RESOLE PHENOLIC RESINS | EASTMAN CHEM CO (US) | 2023-08-30 | — | — | EP | disclosed |
| WO-2004058241-A1 | INHIBITION OF MELANOGENESIS AND MELANOMA METASTASIS WITH P-AMINOBENZOIC ACID (PABA) | NEW YORK UNIVERSITY (US) | 2004-07-15 | — | — | WO | disclosed |
| US-20020123609-A1 | Dendrimeric support or carrier macromolecule | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-09-05 | — | — | US | disclosed |
| WO-2002026867-A2 | DENDRIMERIC SUPPORT OR CARRIER MACROMOLECULE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-04-04 | — | — | WO | disclosed |
| CN-1074898-C | Ionene polymers containing biologically-active anions | BUCKMAN LAB INT INC (US) | 2001-11-21 | — | — | CN | disclosed |
| CN-1162246-A | Ionene polymers containing biologically-active anions | BUCKMAN LABOR INC (US) | 1997-10-15 | — | — | CN | disclosed |
| US-4008175-A | Organic acid anhydride-peroxydicarbonate composition | PPG INDUSTRIES, INC. (US) | 1977-02-15 | — | — | US | disclosed |
| US-3985720-A | Polymerization of ethylenically unsaturated monomer employing a catalyst system comprising dialkylpyrocarbonate, organic acid anhydride, alkaline reagent and H2 O2 | PPG INDUSTRIES, INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3978032-A | ALKALINE BUFFER, ANHYDRIDE, PERACID, ALKYL HALOFORMATE | PPG INDUSTRIES, INC. (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254082-A1 | Substituted Isoindoline-1, 3-diketone PDE4 Inhibitor and Pharmaceutical Application Thereof | PDE4A, PDE4B, PDE3B | LMNA 2923/4885CYP1A2 142/4885CYP3A4 20/4885 |
| US-20020123609-A1 | Dendrimeric support or carrier macromolecule | CD44, TSG101, BST2 | LMNA 1708/4885CYP1A2 4651/4885CYP3A4 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.